Bristol-Myers Squibb
$61.46Change from previous close: −1.51%Absolute change: −$0.94
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- $125.55B
- Enterprise value
- $159.53B
- P/E (trailing 12 months)
- 13.5
- Forward P/E
- 9.36
- PEG
- 17.4
- Price/book
- 5.63
- Price/sales
- 2.55
- EV/EBITDA
- 8.43
- EV/revenue
- 3.24
Profitability and growth
- Gross margin
- 71.7%
- Operating margin
- 34.4%
- Net margin
- 18.9%
- ROE
- 46.6%
- ROA
- 10.7%
- Revenue growth (year over year)
- 5.7%
- Earnings growth (year over year)
- 153.1%
Financial health
- Total cash
- $11.07B
- Total debt
- $45.05B
- Debt/equity
- 2.02
- Current ratio
- 1.53
- Quick ratio
- 1.29
Dividends
- Annual dividend per share
- $2.52
- Dividend yield
- 4.1%
- Payout ratio
- 55.3%
- Ex-dividend date
- October 2, 2026
Analysts and estimates
- Average price target
- $66.71
- Median price target
- $68.00
- High price target
- $82.00
- Low price target
- $40.00
- Analysts with a price target
- 24
- Consensus
- Buy
- Forward EPS
- $6.56
- EPS estimate, current year
- $6.95
Shares and trading
- Beta
- 0.23
- Average volume
- 11.04M
- Shares outstanding
- 2.04B
- Float
- 2.04B
- Institutional ownership
- 84.9%
- Insider ownership
- 0.1%
- Short interest (% of float)
- 2.1%
- Short ratio (days)
- 5.36